This manuscript represents a review of lymphoblastic leukemia/lymphoma (acute
lymphoblastic leukemia/lymphoblastic lymphoma), acute leukemias of ambiguous lineage …

Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy in adults
accounting for 31% of all NHL in Western Countries. Following, morphological, biological …

Diffuse large B-cell lymphoma (DLBCL) can be divided into prognostically important
subgroups with germinal center B-cell–like (GCB), activated B-cell–like (ABC), and type 3 …

Purpose: Hans and coworkers previously developed an immunohistochemical algorithm
with∼ 80% concordance with the gene expression profiling (GEP) classification of diffuse …

Background Several gene-expression signatures can be used to predict the prognosis in
diffuse large-B-cell lymphoma, but the lack of practical tests for a genome-scale analysis has …

Genome studies of diffuse large B-cell lymphoma (DLBCL) have revealed a large number of
somatic mutations and structural alterations. However, the clinical significance of these …

Diffuse large B-cell lymphomas (DLBCLs) can be divided into germinal-center B cell–like
(GCB) and activated-B cell–like (ABC) subtypes by gene-expression profiling (GEP), with the …

BACKGROUND: There is a need to develop novel therapies for relapsed/refractory diffuse
large B‐cell lymphoma (DLBCL) and to identify biomarkers predictive for therapeutic …

Apoptosis, the cell's intrinsic death program, is a key regulator of tissue homeostasis. An
imbalance between cell death and proliferation may result in tumor formation. Also, killing of …

MYC alterations influence the survival of patients with diffuse large B-cell lymphoma. Most
studies have focused on MYC translocations but there is little information regarding the …